Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Analona Therapeutics ApS
APS
Active
Reklamebeskyttelse
CVR 44958821
Ole Maaløes Vej 3, 2200
København N
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2024 · 1 year old
1 employees
Overvåg
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Analona Therapeutics ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Ledelse
Aktivt ansatte i selskabet
Name
Role
Member since
Current (1)
AJ
Axel Johannes Behrens
Chief Executive Officer
Chief Executive Officer
2026
Former (1)
GM
Gert Mads Bolwig
Chief Executive Officer
Chief Executive Officer
2024 – 2026
Bestyrelse
Ikke-udøvende tilsyn
No data on file.
Aktionærer
Pr. seneste årsrapport
Shareholder
Type
Ownership
Votes
Since
AB BIO GmbH
Individual
66.67–89.99%
66.67–89.99%
2024
Mikkel Wandahl Pedersen
Individual
25–33.32%
25–33.32%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Analona Therapeutics ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
